We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Bariatric Surgery Reduces ESRD and Kidney Failure Risk

By HospiMedica International staff writers
Posted on 02 Apr 2018
A new study shows that bariatric surgery is associated with a long-term protection against end-stage renal disease (ESRD) and chronic kidney disease stage 4 (CKD4).

Researchers at the University of Gothenburg (Sweden), Sahlgrenska Academy (SA; Göteborg, Sweden), and other institutions conducted a prospective study in 4,047 patients participating in the Swedish Obese Subjects (SOS) study. More...
The study cohort, consisting of 2,010 patients, underwent banding (18%), vertical banded gastroplasty (69%), or gastric bypass (13%); the 2,037 patients in the control group received usual obesity care. All patients were followed for a median of 18 years. Incidence of ESRD and CKD4 was obtained by crosschecking the SOS database with the Swedish National Patient Register.

The results showed that ESRD occurred in 13 patients in the surgery group and 26 patients in the control group, with 23 CKD4 events in the surgery group and 39 in the control group. Patients who underwent weight-loss surgery ran a significantly lower risk of developing severe chronic kidney disease and ESRD, when compared to conventionally treated patients. Those with initial evidence of kidney damage--as manifested by macroalbuminuria--benefited the most, indicating that bariatric surgery prevents progression of pre-existing kidney injury towards ESRD. The study was published on February 26, 2018, in the International Journal of Obesity.

“Obesity is a major public health problem leading to co-morbidities such as diabetes, hypertension, and kidney failure. Bariatric surgery results in pronounced and maintained weight loss and prevention of obesity-related diseases and their complications,” concluded senior author Per-Arne Svensson, PhD, of the SA Institute of Health and Care Sciences. “Most studies of bariatric surgery on kidney disease show improvements after surgery. Our study showed for the first time that bariatric surgery is associated with a long-term protection against ESRD and CKD4.”

Kidney disease is usually progressive, with each stage determined by glomerular filtration rate (GFR), and dependent on treatment and response. The kidneys of people with ESRD function below 15% of their normal ability. Chronic kidney disease typically does not reach ESRD, the fifth stage of the progression, until 10-20 years after initial diagnosis, at which time the only treatments left include dialysis or a kidney transplant.

Related Links:
University of Gothenburg
Sahlgrenska Academy


Gold Member
12-Channel ECG
CM1200B
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Hypodermic Syringe
SurTract™ Safety Syringe
Resorbable Bovine Collagen Membrane
GenDerm
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Critical Care

view channel
Image Credit: 123RF

AI Platform Screens for Amyloid Cardiomyopathy Using ECG Images

Amyloid cardiomyopathy is a heart disease caused by deposits of misfolded proteins in the cardiac muscle. It is often missed until patients develop serious complications such as heart failure.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.